JIUDIAN PHARMACEUTICAL has been approved to conduct clinical trials for two drugs
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, JIUDIAN PHARMACEUTICAL announced that the company recently received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration. After completing the relevant preparatory work, it will carry out clinical trial research. The approved clinical trials include: JIZM01 for clinical trials of closed soft tissue contusions and joint sprains, and JIZM02 for clinical trials of shoulder periarthritis
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments